Combined application of alginate dressing and human granulocyte‑macrophage colony stimulating factor promotes healing in refractory chronic skin ulcers

Huang,Guobao; Sun,Tangqing; Zhang,Lei; Wu,Qiuhe; Zhang,Keyan; Tian,Qingfen; Huo,Ran

doi:10.3892/etm.2014.1652

Combined application of alginate dressing and human granulocyte‑macrophage colony stimulating factor promotes healing in refractory chronic skin ulcers

Authors:
- Guobao Huang
- Tangqing Sun
- Lei Zhang
- Qiuhe Wu
- Keyan Zhang
- Qingfen Tian
- Ran Huo
View Affiliations

Affiliations: Department of Burn and Plastic Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China, Department of Burn and Plastic Surgery, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China
Published online on: March 31, 2014 https://doi.org/10.3892/etm.2014.1652
Pages: 1772-1776

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to evaluate the clinical therapeutic effect of the combined application of alginate and recombinant human granulocyte‑macrophage colony‑stimulating factor (rhGM‑CSF) on the healing of refractory chronic skin ulcers. A single center, three arm, randomized study was performed at Jinan Central Hospital (Jinan, Shandong, China). A total of 60 patients with refractory chronic skin ulcers, which persisted for >1 month, were enrolled and randomly assigned into one of the following three groups: alginate dressing/rhGM‑CSF group (group A), rhGM‑CSF only group (group B) and conventional (vaseline dressing) group (group C). The wound area rate was measured, granulation and color were observed and pain was evaluated. The data were summarized and statistical analysis was performed. The results demonstrated that group A exhibited a significantly faster wound healing rate and lower pain score compared with the other groups (P<0.01). In conclusion, the combined application of alginate dressing and rhGM‑CSF for the treatment of refractory chronic skin ulcers demonstrated significant advantages. It promoted the growth of granulation tissue, accelerated re‑epithelialization and also effectively reduced wound pain, and thus improved the quality of life for the patient. This suggests that the combined application of alginate and rhGM‑CSF may be an effective therapeutic strategy for the clinical treatment of refractory chronic skin ulcers.

View Figures

View References

1	Barnard J and Millner R: A review of topical hemostatic agents for use in cardiac surgery. Ann Thorac Surg. 88:1377–1383. 2009. View Article : Google Scholar : PubMed/NCBI
2	Niemi T, Svartling N, Syrjälä M, Asko-Seljavaara S and Rosenberg P: Haemostatic disturbances in burned patients during early excision and skin grafting. Blood Coagul Fibrinolysis. 9:19–28. 1998. View Article : Google Scholar : PubMed/NCBI
3	Wee S and Gombotz WR: Protein release from alginate matrices. Adv Drug Deliv Rev. 31:267–285. 1998. View Article : Google Scholar : PubMed/NCBI
4	Groenewold MD, Gribnau AJ and Ubbink DT: Topical haemostatic agents for skin wounds: a systematic review. BMC Surg. 11:152011. View Article : Google Scholar : PubMed/NCBI
5	Rabbany SY, Pastore J, Yamamoto M, Miller T, Rafii S, Aras R and Penn M: Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant. 19:399–408. 2010. View Article : Google Scholar : PubMed/NCBI
6	Kolambkar YM, Dupont KM, Boerckel JD, Huebsch N, Mooney DJ, Hutmacher DW and Guldberg RE: An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials. 32:65–74. 2011. View Article : Google Scholar : PubMed/NCBI
7	Lee KY, Peters MC and Mooney DJ: Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release. 87:49–56. 2003. View Article : Google Scholar : PubMed/NCBI
8	Silva EA and Mooney DJ: Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials. 31:1235–1241. 2010. View Article : Google Scholar : PubMed/NCBI
9	Agren MS: Zinc in wound repair. Arch Dermatol. 135:1273–1274. 1999. View Article : Google Scholar : PubMed/NCBI
10	Murakami K, Aoki H, Nakamura S, Takikawa M, Hanzawa M, Kishimoto S, Hattori H, Tanaka Y, Kiyosawa T, Sato Y and Ishihara M: Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing-impaired wound dressings. Biomaterials. 31:83–90. 2010. View Article : Google Scholar : PubMed/NCBI
11	Wiegand C, Heinze T and Hipler UC: Comparative in vitro study on cytotoxicity, antimicrobial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver-containing alginate. Wound Repair Regen. 17:511–521. 2009. View Article : Google Scholar
12	Hu X, Sun H, Han C, Wang X and Yu W: Topically applied rhGM-CSF for the wound healing: a systematic review. Burns. 37:729–741. 2011. View Article : Google Scholar : PubMed/NCBI
13	Mann A, Breuhahn K, Schirmacher P and Blessing M: Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization. J Invest Dermatol. 117:1382–1390. 2001. View Article : Google Scholar
14	Zhang L, Chen J and Han C: A multicenter clinical trial of recombinant human GM-CSF hydrogel for the treatment of deep second-degree burns. Wound Repair Regen. 17:685–689. 2009. View Article : Google Scholar : PubMed/NCBI
15	da Costa RM, Aniceto C, Jesus FM and Mendes M: Quick healing of leg ulcers after molgramostim. Lancet. 344:481–482. 1994.PubMed/NCBI
16	Ure I, Partsch B, Wolff K and Petzelbauer P: Granulocyte/macrophage colony-stimulating factor increases wound-fluid interleukin 8 in normal subjects but does not accelerate wound healing. Br J Dermatol. 138:277–282. 1998. View Article : Google Scholar
17	De Ugarte DA, Roberts RL, Lerdluedeeporn P, Stiehm ER and Atkinson JB: Treatment of chronic wounds by local delivery of granulocyte-macrophage colony-stimulating factor in patients with neutrophil dysfunction. Pediatr Surg Int. 18:517–520. 2002.PubMed/NCBI
18	Jorgensen LN, Agren MS, Madsen SM, Kallehave F, Vossoughi F, Rasmussen A and Gottrup F: Dose-dependent impairment of collagen deposition by topical granulocyte-macrophage colony-stimulating factor in human experimental wounds. Ann Surg. 236:684–692. 2002. View Article : Google Scholar
19	Breuhahn K, Mann A, Müller G, Wilhelmi A, Schirmacher P, Enk A and Blessing M: Epidermal overexpression of granulocyte-macrophage colony-stimulating factor induces both keratinocyte proliferation and apoptosis. Cell Growth Differ. 11:111–121. 2000.
20	Jaschke E, Zabernigg A and Gattringer C: Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers. Int J Dermatol. 38:380–386. 1999. View Article : Google Scholar
21	Queen D, Orsted H, Sanada H and Sussman G: A dressing history. Int Wound J. 1:59–77. 2004. View Article : Google Scholar
22	Winter GD: Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature. 193:293–294. 1962. View Article : Google Scholar
23	Yang Y, Wang J and Zhu L: Alginate dressing application in plastic surgery. Journal of Chinese and Western Medicine. 5:108–111. 2010.
24	Balakrishnan B, Mohanty M, Fernandez AC, Mohanan PV and Jayakrishnan A: Evaluation of the effect of incorporation of dibutyryl cyclic adenosine monophosphate in an in situ-forming hydrogel wound dressing based on oxidized alginate and gelatin. Biomaterials. 27:1355–1361. 2006. View Article : Google Scholar
25	Huang C, Wen X and Li G: Efficacy observation and nursing for decubitus treated with Alginate dressing. Modern Medicine & Health. 23:22007.
26	Ye Q and Chen J: Alginate dressing application for skin graft on donor site. Zhejiang Medicine. 23:52001.
27	Da Costa RM, Ribeiro Jesus FM, Aniceto C and Mendes M: Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers. Wound Repair Regen. 7:17–25. 1999.PubMed/NCBI
28	Du S, Li Y, Mao Y, Sang X, Lu X, Wang W, Zhang Q, Xue H, Yang X, Li S, Chi T, Zhong S and Huang J: Diagnosis and treatment of hepatic angiomyolipoma. Hepatobiliary Surg Nutr. 1:19–24. 2012.
29	Kaplan G, Walsh G, Guido LS, Meyn P, Burkhardt RA, Abalos RM, Barker J, Frindt PA, Fajardo TT and Celona R: Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med. 175:1717–1728. 1992. View Article : Google Scholar
30	Siddiqui FH, Mokhashi MH and Boathman A: Recombinant granulocyte-macrophage colony-stimulating factor in the treatment of indolent ulcers with Klippel-Trenaunay-Weber syndrome: a case report. J Pediatr Surg. 42:558–560. 2007. View Article : Google Scholar
31	Tursen U, Api H, Kaya TI, Cinel L and Ikizoglu G: Rapid healing of chronic leg ulcers during perilesional injections of granulocyte-macrophage colony-stimulating factor therapy in a patient with cutaneous polyarteritis nodosa. J Eur Acad Dermatol Venereol. 20:1341–1343. 2006. View Article : Google Scholar